Table 2 Study characteristics at the meso-/macro-level (sorted by medical domain)
Author (year) | Domain | Patients | Number of patients | PROM(s) used (GEN = generic, DS = disease-specific) | Overall impact | Quality of study |
|---|---|---|---|---|---|---|
Benchmarking | ||||||
Boyce (2015) | Orthopedics | Receiving primary hip arthroplasty | I:230; C:228 | OHS (DS) | ~ | Weak |
Varagunam (2014) | Orthopedics and general surgery | Receiving hip or knee arthroplasty, varicose vein or inguinal hernia surgery | I: 7 k-30 k; C:NA | EQ-5D-5L (GEN), EQ VAS (GEN), 1 of 3 disease-specific questionnaires (OHS, OKS, AVVQ) | ~ | Moderate |
Weingarten (2000) | Primary care | Elderly | I:541; C:543 | Dartmouth COOP (GEN) | ~ | Moderate |
Kumar (2021) | Urology | Undergoing prostate surgery for cancer | I:212; C:210 | Selected items (continence, sexual function) from the EPIC (DS) | - | Weak |
In-depth analysis of data | ||||||
Haller (2011) | Internal and surgical departments | Wards | I:1237; C:1113 | IPO questionnaire (DS), NRS pain | + | Moderate |
Zaslansky (2019) | Surgical departments | Wards | I:? C:? | IPO questionnaire (DS), NRS pain | + | Weak |
Garduño-López (2021) | Surgical departments | Wards | I:? C:? | IPO questionnaire (DS), NRS pain | + | Weak |
PDCA-cycle | ||||||
Partridge (2016) | Orthopedics | Patient receiving total knee arthroplasty | I:827, C:441 | OKS (DS), EQ-5D-3L (GEN) | + | Moderate |